SYRACUSE — M. Jack Rudnick, of counsel with Hiscock & Barclay, LLP, has been appointed director of the Technology Commercialization Law Program at the Syracuse University College of Law.
Rudnick leads the Emerging Technology team at Hiscock & Barclay. He has previously served as vice president and general counsel at Welch Allyn and before that at Oneida Ltd. Rudnick was also previously senior vice president of legal and government affairs at Blue Highway.
A graduate of the Syracuse University College of Law in 1973, Rudnick has served as an adjunct professor since 1995.
(Sponsored)
How CH Insurance’s BOOST Program Optimizes Group Benefits for Small Businesses
For small business owners, navigating the complexities of group benefits can be overwhelming. Between compliance regulations, cost considerations, and employee expectations, offering a competitive benefits package often feels like a
Fraud Contingencies Plans Are Essential
Your business likely has a disaster recovery plan in place—procedures for handling fires, natural disasters or other crises that could disrupt operations or endanger lives. While a fraud contingency plan
SU’s Technology Commercialization Law Program provides law students with experiential learning in transforming new technologies into market-ready products and services, and brings together second- and third-year law students with real companies and entrepreneurs across the state, according to the university.
“Jack’s appointment highlights his skills at helping new technologies and new businesses grow from ideas to real-world market successes,” John P. Langan, managing partner at Hiscock & Barclay, said in a news release.
Rudnick will continue in his role at Hiscock & Barclay. “I look forward to continuing my work,” he said in the release. “Maybe I’ll get to share some of what I learn from these students.”
Hiscock & Barclay, listed as a “Top 250 Firm” by The National Law Journal, is a full-service, 200-attorney law firm, with offices throughout the major cities of New York state, as well as in Boston, Washington, Newark, N.J., and Toronto.
